Nicotine's New Frontier: Big Tobacco's War on the Illicit Market
- 12% of high school students have experimented with nicotine pouches (OTRU report).
- Siberia 35 mg pouches contain 9x the nicotine of a standard 4 mg ZONNIC pouch.
- Health Canada recalled unregulated nicotine pouches in late 2025.
Experts agree that while Big Tobacco's focus on the illicit market is strategically framed, the broader issue of youth nicotine addiction requires stricter regulations on all nicotine products, not just illegal ones.
Nicotine's New Frontier: Big Tobacco's War on the Illicit Market
MONTREAL, QC – June 11, 2026
A new report from the Ontario Tobacco Research Unit (OTRU) has sent a shockwave through Canada's public health landscape, revealing that 12% of high school students have experimented with nicotine pouches. The data paints a stark picture of a new generation becoming acquainted with nicotine through a discreet, smokeless product. Yet, in a masterclass of strategic communication, Imperial Tobacco Canada (ITCAN), the nation’s largest tobacco firm, has seized this moment not as a crisis for its industry, but as an opportunity to frame the narrative, positioning itself as a key ally in the fight to protect youth.
Responding to the OTRU data, ITCAN immediately pointed the finger away from regulated products and towards a shadowy, uncontrolled digital marketplace. "Any increase in youth exposure to nicotine products is concerning and demands serious attention," said Eric Gagnon, the company's Vice President of Corporate & Regulatory Affairs. "But if we are serious about protecting young people, we need to focus on where these products are coming from." For ITCAN, the source is clear: a burgeoning illegal market operating entirely outside of federal oversight. This is more than a press release; it’s a strategic salvo in the battle for the future of nicotine in Canada.
The Two-Front War on Nicotine Pouches
To understand Imperial Tobacco's position, one must first grasp the divided reality of Canada's nicotine pouch market. On one side stands ZONNIC, ITCAN’s own offering. It is a Health Canada-authorized Nicotine Replacement Therapy (NRT) product, sold exclusively behind the counter in pharmacies, intended to help adult smokers quit. Its sale is restricted, its marketing is controlled, and its purpose is therapeutic.
On the other side is a sprawling, unregulated bazaar. This is the world of illegally imported products like ZYN 6 mg and the alarmingly potent Siberia 35 mg pouches—products Health Canada recalled late last year for being sold without market authorization. These illicit pouches are the true culprits, according to ITCAN. They are sold through online channels with little to no age verification, often feature flavours like fruit and mint designed to appeal to younger palates, and contain nicotine levels far exceeding what is found in authorized NRTs. The Siberia pouches, with 35 mg of nicotine, contain nearly nine times the dose of a standard 4 mg ZONNIC pouch, creating a significant risk for rapid addiction, especially in nicotine-naïve adolescents.
"Despite strict regulatory controls on authorized nicotine replacement therapy pouches, youth use continues to rise," Gagnon argued, highlighting the recent recall. "That should be a clear signal: the real issue is a growing illicit market operating entirely outside the regulatory framework." By drawing this bright line between its “good” legal product and the “bad” illegal ones, ITCAN constructs a simple, compelling narrative: the problem isn't the product, it's the criminals.
A Calculated Call to Arms
From the perspective of corporate strategy, Imperial Tobacco’s call for a crackdown is a brilliant, multi-faceted maneuver. As a subsidiary of British American Tobacco (BAT), a global giant pursuing a “Smokeless World” through its “A Better Tomorrow™” initiative, this move perfectly aligns with its long-term business objectives. The strategy serves to protect its regulated market share, polish its corporate image, and subtly influence the regulatory environment in its favor.
First, by championing enforcement against illicit competitors, ITCAN protects its commercial turf. A successful crackdown on the unregulated market would eliminate a source of intense competition for ZONNIC, funneling adult users seeking smokeless options towards the few legally sanctioned channels where ITCAN dominates. Second, it allows the company to position itself as a responsible public health partner. This advocacy helps build goodwill with regulators and the public, reinforcing the harm-reduction narrative that is central to BAT's global pivot away from combustible cigarettes. It’s a powerful way to say, “We are part of the solution.”
Third, and most critically, it shifts the blame. By focusing exclusively on the illegal supply chain, the narrative deflects attention from the more uncomfortable question of whether the very existence and promotion of legal nicotine products, even as NRTs, contributes to the normalization and initiation of nicotine use among youth. The company’s lobbying records show consistent engagement with federal officials on topics of illegal trade and product regulation, demonstrating a sustained effort to shape this exact narrative. This is not a reactive statement; it is the public-facing component of a deeply entrenched corporate strategy to define the terms of the nicotine debate.
The Unimpressed Chorus of Public Health
While ITCAN’s argument is strategically sound, it has been met with deep skepticism from the public health community. For organizations like the Canadian Cancer Society and Action on Smoking and Health, the distinction between a legal and illegal nicotine pouch is secondary to the primary threat: nicotine addiction itself.
"Focusing solely on the illegal market is a convenient misdirection," stated a senior policy analyst at a leading Canadian health charity, who spoke on the condition of anonymity. "Nicotine is highly addictive and harmful to the developing adolescent brain, regardless of whether it's sold in a pharmacy or from an anonymous website. The industry is creating a new generation of nicotine users while claiming to solve a problem it profits from." Advocates argue that the proliferation of any new nicotine product, coupled with industry marketing, inevitably raises awareness and curiosity among youth. They point to the rise of vaping as a cautionary tale where a product initially marketed for harm reduction created a new epidemic of youth addiction.
These groups advocate for a much broader approach. They demand stricter regulations on all nicotine products, including comprehensive flavour bans, plain packaging, and prohibitions on marketing that could be perceived by young people. For them, ITCAN’s call for enforcement, while welcome, addresses only a symptom, not the root cause of rising youth nicotine dependency.
Ottawa's Regulatory Tightrope
Caught in the middle is Health Canada, which is walking a difficult regulatory tightrope. The department is not, as some might infer from ITCAN’s plea, standing idle. It has already acted, issuing recalls and public warnings. More significantly, in June 2023, the federal government announced its intention to amend regulations to treat all nicotine pouches containing 4 mg or more of nicotine as vaping products, subjecting them to flavour restrictions and marketing prohibitions, regardless of their NRT status. This proactive move aims to close the very regulatory loophole that has allowed some non-NRT pouches to enter a grey market.
However, the government faces immense enforcement challenges that lend some credibility to ITCAN's position. The digital marketplace is a global hydra; shutting down one illicit online vendor sees two more spring up. The Canada Border Services Agency (CBSA) is tasked with the monumental job of intercepting small, easily concealed packages among millions of daily imports. This operational reality means that even with tougher regulations, a determined illicit market will persist.
Imperial Tobacco Canada has skillfully leveraged a genuine public health crisis to advance its strategic interests. By calling for a war on an enemy everyone can agree on—illegal sellers endangering children—it burnishes its own credentials as a responsible actor. Yet, the broader public health community remains wary, seeing the maneuver as an attempt to control a narrative and protect a new and vital revenue stream. In the high-stakes battle for the future of nicotine, the line between public health partner and market strategist is becoming increasingly blurred, leaving regulators and parents to navigate the fallout.
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →